Drug Shortage Report for ADYNOVATE

Last updated on 2021-01-06 History
Report ID 128401
Drug Identification Number 02498626
Brand name ADYNOVATE
Common or Proper name Antihemophilic Factor (Recombinant), Pegylated
Company Name TAKEDA CANADA INC
Market Status MARKETED
Active Ingredient(s) ANTIHEMOPHILIC FACTOR
Strength(s) 3000UNIT
Dosage form(s) KIT POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 5mL, 3000 IU/UI
ATC code B02BD
ATC description VITAMIN K AND OTHER HEMOSTATICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-12-01
Actual start date 2020-12-01
Estimated end date 2020-12-31
Actual end date 2021-01-05
Shortage status Resolved
Updated date 2021-01-06
Company comments Resolved as of 05Jan2021
Health Canada comments
Tier 3 Status No
Contact Address 22 ADELAIDE STREET WEST
TORONTO, ONTARIO
CANADA M5H 4E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-01-06 English Compare
v8 2021-01-05 French Compare
v7 2021-01-05 English Compare
v6 2021-01-05 French Compare
v5 2021-01-05 French Compare
v4 2021-01-05 English Compare
v3 2020-12-02 English Compare
v2 2020-11-13 French Compare
v1 2020-11-13 English Compare

Showing 1 to 9 of 9